Blog
Articles, guides, and regulatory updates from our community.
Peptide Therapy for Gut Health: From IBS to Intestinal Permeability
How peptides like BPC-157, larazotide, and KPV are being studied for gastrointestinal conditions — from inflammatory bowel disease to intestinal barrier repair.
By Peptide Association Editorial Team
How Peptide Therapy Is Transforming Weight Management
The GLP-1 revolution has rewritten the rules of obesity treatment. How incretin-based peptide therapies achieve what diet and exercise alone cannot — and what comes next.
By Peptide Association Editorial Team
Peptide Therapy Safety: What Every Patient Should Know
A comprehensive safety guide covering side effects, drug interactions, quality concerns, and red flags — essential reading for anyone considering or currently using peptide therapy.
By Peptide Association Editorial Team
FDA Peptide Regulation in 2026: What Providers Need to Know
The regulatory landscape for compounded peptides has shifted dramatically. Here's what clinicians must understand about FDA enforcement, 503A/503B rules, and the bulk drug substance list.
By Peptide Association Editorial Team
BPC-157: What the Research Actually Shows
An honest assessment of BPC-157 research — separating the extensive animal data from the limited human evidence, and what providers should tell patients asking about this popular peptide.
By Peptide Association Editorial Team
Compounding Pharmacies and Peptide Quality: A Provider Guide
How to evaluate compounding pharmacies, understand USP standards, interpret certificates of analysis, and ensure your patients receive safe, accurately dosed peptide products.
By Peptide Association Editorial Team
GHK-Cu: The Anti-Aging Peptide Backed by Science
How the copper-binding tripeptide GHK-Cu influences wound healing, collagen synthesis, and gene expression — and what the evidence says about its anti-aging potential.
By Peptide Association Editorial Team
NAD+ and Longevity: The Role of Mitochondrial Peptides
How mitochondrial-derived peptides like MOTS-c and humanin intersect with NAD+ biology to influence aging, metabolic health, and cellular resilience.
By Peptide Association Editorial Team
Semaglutide vs Tirzepatide: Comparing GLP-1 Therapies
A head-to-head comparison of the two leading GLP-1 receptor agonists — mechanisms of action, clinical trial data, side effects, and practical considerations for providers and patients.
By Peptide Association Editorial Team
The Science Behind Growth Hormone Secretagogues
How CJC-1295, ipamorelin, tesamorelin, and other GH secretagogues work — the physiology, clinical evidence, and practical protocols for growth hormone optimization.
By Peptide Association Editorial Team
Understanding Thymosin Alpha 1 for Immune Support
A deep dive into thymosin alpha-1 — the endogenous thymic peptide with decades of clinical research supporting its role in immune modulation, viral infections, and as an immunotherapy adjunct.
By Peptide Association Editorial Team
What Is Peptide Therapy? A Complete Guide for 2026
Everything you need to know about peptide therapy — from the science behind short-chain amino acids to clinical applications, delivery methods, and how to find a qualified provider.
By Peptide Association Editorial Team
PT-141: The First FDA-Approved Peptide for Sexual Health
How bremelanotide (PT-141) works through melanocortin receptors to address hypoactive sexual desire disorder — mechanism, clinical data, and practical prescribing considerations.
By Peptide Association Editorial Team
Peptide Therapy for Sleep and Recovery Optimization
How peptides like DSIP, epitalon, and GH secretagogues can support sleep architecture, recovery, and circadian health — the evidence and practical protocols.
By Peptide Association Editorial Team